Abstract Based on previous reports of certain 5-deazaflavin derivatives being capable of activating the tumour suppressor p53 in cancer cells through inhibition of the p53-specific ubiquitin E3 ligase HDM2, we have conducted an structure–activity relationship (SAR) analysis through systematic modification of the 5-deazaflavin template. This analysis shows that HDM2-inhibitory activity depends on a combination of factors. The most active ...
[Nagamatsu, Tomohisa; Hashigushi, Yuko; Higuchi, Masatsugu; Yoneda, Fumio Journal of the Chemical Society, Chemical Communications, 1982 , # 18 p. 1085 - 1086]